Earnings

Apple Q1 2025 Earnings Preview: Core Value Remains Strong As Stock Ripens (AAPL) – Go Health Pro

by
Apple Q1 2025 Earnings Preview: Core Value Remains Strong As Stock Ripens (AAPL) – Go Health Pro

This article was written by Follow At Investors’ Edge, we specialise in identifying undervalued companies with strong fundamentals and great growth potential. Our rigorous value investing approach combines thorough fundamental analysis with a focus on companies trading significantly below their intrinsic value.We prioritise businesses with robust cash flows, strong balance sheets, and competent management teams … Read more

Zacks Small Cap Research – LOBO: Busy Quarter on the Product/Distribution/Capital Fronts; Earnings Power Set to Ramp Up – Go Health Pro

by

By Michael Kim NASDAQ:LOBO LOBO EV Technologies (NASDAQ:LOBO) designs and manufactures e-Bicycles, e-Mopeds, motorcycles, e-Tricycles, autonomous robotic lawn mowers, and electric off-highway four-wheeled shuttles (golf carts and scooters for elderly and disabled persons) for distribution through a broad-based dealership network in China, Southeast Asia, Latin America, Europe, and the United States. Following the release of … Read more

Allstate to hold Q4 2024 earnings call Feb. 6 – Go Health Pro

by
Allstate to hold Q4 2024 earnings call Feb. 6 – Go Health Pro

NORTHBROOK, Ill., Jan. 7, 2025 – The Allstate Corporation (NYSE: ALL) will host a conference call and webcast at 9 a.m. ET on Thursday, Feb. 6, 2025, to discuss fourth quarter 2024 financial results. Allstate plans to file its results via a Form 8-K with the Securities and Exchange Commission (SEC) after 4:15 p.m. ET … Read more

Zacks Small Cap Research – QSG: F1Q25 Earnings Review: EPS Miss on Lower Revenues; Silver Transition Gaining Momentum – Go Health Pro

by

By Michael Kim NASDAQ:QSG READ THE FULL QSG RESEARCH REPORT Pre-market open on 11/27/24, QuantaSing (NASDAQ:QSG) reported F1Q25 (Sep) earnings results. On a GAAP basis, QSG reported net income of $11.5 million for F1Q25, or $0.21 per ADS. That said, excluding share-based compensation expenses, adjusted EPS came in at $0.23, or below our estimate of … Read more

Zacks Small Cap Research – BENF: F2Q25 Earnings Review: Improving Financial Performance; Pivoting to Growth – Go Health Pro

by

By Michael Kim NASDAQ:BENF READ THE FULL BENF RESEARCH REPORT After the market closed on 11/14/24, Beneficient (NASDAQ:BENF) reported F2Q25 (Sep) earnings results. On a GAAP basis, BENF reported net income of $0.03 per Class A diluted share for F2Q25 – the company’s second consecutive profitable quarter as a public company – versus a loss … Read more